WO1996040768A3 - Anti-fungal and anti-bacterial histatin-based peptides - Google Patents
Anti-fungal and anti-bacterial histatin-based peptides Download PDFInfo
- Publication number
- WO1996040768A3 WO1996040768A3 PCT/US1996/009374 US9609374W WO9640768A3 WO 1996040768 A3 WO1996040768 A3 WO 1996040768A3 US 9609374 W US9609374 W US 9609374W WO 9640768 A3 WO9640768 A3 WO 9640768A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fungal
- based peptides
- histatin
- bacterial
- naturally occurring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69610424T DE69610424T2 (en) | 1995-06-07 | 1996-06-07 | HISTATINE-BASED PEPTIDES AGAINST MUSHROOMS AND BACTERIA |
CA002223505A CA2223505C (en) | 1995-06-07 | 1996-06-07 | Anti-fungal and anti-bacterial histatin-based peptides |
AT96919182T ATE196475T1 (en) | 1995-06-07 | 1996-06-07 | HISTATIN-BASED, ANTI-FUNGAL AND BACTERIAL PEPTIDES |
DK96919182T DK0832119T3 (en) | 1995-06-07 | 1996-06-07 | Histatin-based peptides against fungi and bacteria |
US08/973,559 US5912230A (en) | 1991-11-01 | 1996-06-07 | Anti-fungal and anti-bacterial histatin-based peptides |
JP9501707A JPH11508238A (en) | 1995-06-07 | 1996-06-07 | Antifungal and antibacterial histatin peptides |
EP96919182A EP0832119B1 (en) | 1995-06-07 | 1996-06-07 | Anti-fungal and anti-bacterial histatin-based peptides |
AU61585/96A AU709204B2 (en) | 1995-06-07 | 1996-06-07 | Anti-fungal and anti-bacterial histatin-based peptides |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/481,888 US5631228A (en) | 1991-11-01 | 1995-06-07 | Anti-fungal and anti-bacterial histatin-based peptides |
US08/481,888 | 1995-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1996040768A2 WO1996040768A2 (en) | 1996-12-19 |
WO1996040768A3 true WO1996040768A3 (en) | 1997-03-06 |
Family
ID=23913789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/009374 WO1996040768A2 (en) | 1991-11-01 | 1996-06-07 | Anti-fungal and anti-bacterial histatin-based peptides |
Country Status (11)
Country | Link |
---|---|
US (1) | US5631228A (en) |
EP (1) | EP0832119B1 (en) |
JP (1) | JPH11508238A (en) |
AT (1) | ATE196475T1 (en) |
AU (1) | AU709204B2 (en) |
CA (1) | CA2223505C (en) |
DE (1) | DE69610424T2 (en) |
DK (1) | DK0832119T3 (en) |
ES (1) | ES2151172T3 (en) |
IL (1) | IL122386A0 (en) |
WO (1) | WO1996040768A2 (en) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6025326A (en) * | 1995-07-07 | 2000-02-15 | Intrabiotics Pharmaceuticals, Inc. | Compositions and methods for the prevention and treatment of oral mucositis |
SK56598A3 (en) * | 1995-11-03 | 1998-09-09 | Unilever Nv | Natural composition for combatting fungi |
US6531573B1 (en) | 1997-12-18 | 2003-03-11 | Trustees Of Boston University | Antifungal and antibacterial peptides |
NL1008745C2 (en) * | 1998-03-30 | 1999-10-01 | Stichting Tech Wetenschapp | New peptide conjugates useful for treating yeast, fungal and bacterial infections and tumors |
US8283315B2 (en) | 1998-08-28 | 2012-10-09 | Lytix Biopharma As | Inhibition of tumour growth |
GB9818938D0 (en) | 1998-08-28 | 1998-10-21 | Alpharma As | Bioactive peptides |
US6528488B2 (en) * | 1999-01-08 | 2003-03-04 | Demegen, Inc. | Method for treating cystic fibrosis |
US6800291B1 (en) * | 1999-03-24 | 2004-10-05 | Zengen, Inc. | Uro-genital condition treatment system |
US6833435B2 (en) * | 1999-08-23 | 2004-12-21 | Matthew Glenn | Compositions isolated from bovine tissues and methods for their use |
US7632803B2 (en) | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US20030158111A1 (en) * | 1999-10-01 | 2003-08-21 | David Bar-Or | Methods and products for oral care |
US7592304B2 (en) | 1999-10-01 | 2009-09-22 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
CA2285673C (en) | 1999-10-21 | 2008-07-29 | Gilles Andre Lajoie | Cyclic analogs of histatins |
US6858581B2 (en) | 2000-06-16 | 2005-02-22 | Arizona State University | Chemically-modified peptides, compositions, and methods of production and use |
US6726898B2 (en) | 2000-11-17 | 2004-04-27 | Gary R. Jernberg | Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease |
US6576226B1 (en) * | 2000-11-17 | 2003-06-10 | Gary R. Jernberg | Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease |
US7090497B1 (en) | 2001-02-21 | 2006-08-15 | Harris David M | Method of periodontal laser treatment |
US20040127892A1 (en) * | 2002-01-31 | 2004-07-01 | Harris David M. | Periodontal laser and methods |
US7033769B2 (en) | 2002-05-23 | 2006-04-25 | The United States Of America As Represented By The Secretary Of The Army | Method for discovering one or more peptides adapted for specific binding to a microorganism of interest |
US7087228B2 (en) * | 2002-07-03 | 2006-08-08 | University Of Southern California | Preventing tooth decay and infective endocarditis using natural oligopeptides |
AU2004227999B2 (en) | 2003-04-01 | 2009-09-24 | Proactive Oral Solutions, Inc. | Caries risk test for predicting and assessing the risk of disease |
US9127045B2 (en) * | 2005-11-17 | 2015-09-08 | University Of Southern California | Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides |
WO2009005798A2 (en) * | 2007-07-03 | 2009-01-08 | Pacgen Biopharmaceuticals Corporation | Antifungal formulation and method of preparation |
US9115180B2 (en) | 2008-01-07 | 2015-08-25 | Rapid Pathogen Screening, Inc. | Use of peptides for promoting wound healing |
MX2010007442A (en) | 2008-01-07 | 2010-12-21 | Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg | Use of peptides for promoting wound healing. |
US20100047734A1 (en) * | 2008-08-20 | 2010-02-25 | PathoLase, Inc. | Periodontal laser treatment and laser applicator |
EP2536379A2 (en) * | 2010-02-19 | 2012-12-26 | The University Of South Dakota | Rechargeable long-term antifungal denture materials |
US20130310327A1 (en) * | 2012-05-18 | 2013-11-21 | Rapid Pathogen Screening, Inc. | Histatin for Corneal Wound Healing and Ocular Surface Disease |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
US20170022256A1 (en) * | 2015-07-23 | 2017-01-26 | General Biologicals Corporation | Anti-fungal and anti-bacterial peptide and therapeutic method using same |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
EP4294825A1 (en) * | 2021-02-16 | 2023-12-27 | The University of Hong Kong | Antibacterial and mineralizing compositions and methods of use thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994021672A1 (en) * | 1993-03-19 | 1994-09-29 | The Regents Of The University Of California | Novel antimicrobial peptides from bovine neutrophils |
US5486503A (en) * | 1991-11-01 | 1996-01-23 | The Trustees Of Boston University | Anti-fungal histatin-based peptides |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4725576A (en) * | 1983-12-29 | 1988-02-16 | Research Foundation Of State University Of New York | Fungicidal polypeptide compositions containing L-histidine and methods for use therefore |
US5032574A (en) * | 1988-05-26 | 1991-07-16 | Invitron Corporation | Novel antimicrobial peptide |
US5221732A (en) * | 1988-12-06 | 1993-06-22 | The United States Of America As Represented By The Department Of Health And Human Services | Antimicrobial magainin modified peptides |
JP2818056B2 (en) * | 1990-09-07 | 1998-10-30 | 森永乳業株式会社 | Antimicrobial peptides and antimicrobial agents |
US5225399A (en) * | 1991-04-15 | 1993-07-06 | The Children's Hospital Of Philadelphia | Antimicrobial amphiphilic peptides |
US5239059A (en) * | 1991-05-10 | 1993-08-24 | The Children's Hospital Of Philadelphia | Ion-channel forming peptides |
US5324716A (en) * | 1991-06-14 | 1994-06-28 | Regents Of The University Of California | Broad spectrum antimicrobial compounds and methods of use |
JPH06234653A (en) * | 1993-02-10 | 1994-08-23 | Sunstar Inc | Periodontium regeneration accelerating agent and material therefor |
JPH06287146A (en) * | 1993-03-31 | 1994-10-11 | Sunstar Inc | External agent for skin |
-
1995
- 1995-06-07 US US08/481,888 patent/US5631228A/en not_active Expired - Lifetime
-
1996
- 1996-06-07 AU AU61585/96A patent/AU709204B2/en not_active Ceased
- 1996-06-07 EP EP96919182A patent/EP0832119B1/en not_active Expired - Lifetime
- 1996-06-07 AT AT96919182T patent/ATE196475T1/en active
- 1996-06-07 IL IL12238696A patent/IL122386A0/en unknown
- 1996-06-07 DK DK96919182T patent/DK0832119T3/en active
- 1996-06-07 ES ES96919182T patent/ES2151172T3/en not_active Expired - Lifetime
- 1996-06-07 CA CA002223505A patent/CA2223505C/en not_active Expired - Fee Related
- 1996-06-07 WO PCT/US1996/009374 patent/WO1996040768A2/en active IP Right Grant
- 1996-06-07 JP JP9501707A patent/JPH11508238A/en active Pending
- 1996-06-07 DE DE69610424T patent/DE69610424T2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486503A (en) * | 1991-11-01 | 1996-01-23 | The Trustees Of Boston University | Anti-fungal histatin-based peptides |
WO1994021672A1 (en) * | 1993-03-19 | 1994-09-29 | The Regents Of The University Of California | Novel antimicrobial peptides from bovine neutrophils |
Non-Patent Citations (2)
Title |
---|
P.A. RAJ ET AL.: "Salivary Histatin 5: Dependence of Sequence, Chain Length, and Helical Conformation for Candidacidal Activity", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 7, 5 March 1990 (1990-03-05), BALTIMORE, MD US, pages 3898 - 3905, XP002020121 * |
R.F. TROXLER ET AL.: "Structural relationship between human salvary histatins", JOURNAL OF DENTAL RESEARCH, vol. 69, no. 1, January 1990 (1990-01-01), pages 2 - 6, XP000611621 * |
Also Published As
Publication number | Publication date |
---|---|
DE69610424T2 (en) | 2001-01-25 |
US5631228A (en) | 1997-05-20 |
DK0832119T3 (en) | 2000-11-20 |
WO1996040768A2 (en) | 1996-12-19 |
IL122386A0 (en) | 1998-06-15 |
EP0832119A2 (en) | 1998-04-01 |
DE69610424D1 (en) | 2000-10-26 |
AU709204B2 (en) | 1999-08-26 |
CA2223505C (en) | 2003-10-14 |
AU6158596A (en) | 1996-12-30 |
CA2223505A1 (en) | 1996-12-19 |
ES2151172T3 (en) | 2000-12-16 |
JPH11508238A (en) | 1999-07-21 |
EP0832119B1 (en) | 2000-09-20 |
ATE196475T1 (en) | 2000-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1996040768A3 (en) | Anti-fungal and anti-bacterial histatin-based peptides | |
WO1996040770A3 (en) | Anti-fungal d-amino acid histatin-based peptides | |
WO2003015809A3 (en) | Antimicrobial cationic peptides and formulations thereof | |
AU6549898A (en) | Method for the broad based treatment of infections, especially infections of organs such as the skin and vagina | |
CA2381770A1 (en) | Human ctla-4 antibodies and their uses | |
AU5370096A (en) | Method of treating or preventing non-viral microbial infection | |
AU1879697A (en) | Peptide immunogens for vaccination against and treatment of allergy | |
AU1679795A (en) | Anti-fungal methods and materials | |
CA2253837A1 (en) | Therapeutic uses of bpi protein products for human meningococcemia | |
WO1996038473A3 (en) | Antimicrobial cationic peptides | |
AU3909497A (en) | Anti-chlamydial methods and materials | |
MX9710252A (en) | Use of one or more peptides in a cosmetic composition or for the preparation of a medicament. | |
AU2967595A (en) | Anti-protozoan methods and materials | |
AU1067599A (en) | Peptide compositions for the treatment and prevention of hiv infection | |
WO2000000214A3 (en) | Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms | |
EP0744176A3 (en) | Methods for inhibiting bone loss | |
AU1278600A (en) | Novel therapeutic application of nicergoline | |
AU5981496A (en) | Cell-cycle regulatory proteins from human pathogens, and use s related thereto | |
AU4602897A (en) | Method for treatment of immunodeficiency virus infection | |
WO1997017072A3 (en) | Use of flupirtin for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system | |
AU1820499A (en) | Compounds and methods for the diagnosis and treatment of (b. microti) infection | |
EP1174439A3 (en) | Compositions and methods for treating infections using analogues of indolicidin | |
AU9334098A (en) | Molecular diagnostic of glaucomas associated with chromosomes 1, and method of treatment thereof | |
EP1574579A3 (en) | Outer surface proteins, their genes, and their use | |
AU6251594A (en) | Treatment of cancerous growths with biologically active peptides and protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1996919182 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1997 501707 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 08973559 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1996919182 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2223505 Country of ref document: CA Ref country code: CA Ref document number: 2223505 Kind code of ref document: A Format of ref document f/p: F |
|
WWG | Wipo information: grant in national office |
Ref document number: 1996919182 Country of ref document: EP |